Ferrer Taps Nonprofit Medina’s Natural Products Library in Search of New Antibiotics – Genetic Engineering News

Grupo Ferrer’s existing drug pipeline includes two clinical-stage antibiotics. Ozenoxacin is a nonfluorinated quinolone, which is undergoing Phase III evaluation as a potential treatment for topical infections. Arasertaconazole is an azole …